Abstract
Intracellular cyclic AMP (cAMP) increased by extracellular stimuli induces various biological effects, such as cell proliferation, differentiation, and migration. Previous reports regarding the effect of cAMP on keratinocyte proliferation are contradictory and indicate that the effect apparently depends on cellular density. Recent studies have revealed that cAMP signaling regulates cell proliferation by modulating mitogen-activated protein kinase (MAPK) activity. The precise mechanism by which cAMP affects keratinocyte proliferation and/or the crosstalk between the cAMP and MAPK signaling pathways, however, remain to be determined. Using normal human keratinocytes (NHK), we investigated the effect of cAMP on keratinocyte proliferation and its molecular mechanism in terms of cellular density. In confluent NHK, cyclic AMP decreased extracellular regulated kinase (ERK) phosphorylation and cell proliferation in a Ras-independent and Rap1-dependent manner. The decreased cell proliferation by cAMP was blocked by the MEK-1 inhibitor, PD98059. In contrast, in subconfluent NHK, cAMP increased ERK phosphorylation and cell proliferation. Western blot analysis revealed that NHK expressed B-Raf and Rap-1. Although both 95 kDa and 62 kDa B-Raf isoforms were expressed in subconfluent NHK, only 62 kDa B-Raf was detected in confluent NHK. Transfection of 95 kDa B-Raf into confluent NHK resulted in a cAMP-dependent increase in ERK phosphorylation and cell proliferation. These findings indicate that differential expression of B-Raf isoforms is critical for cAMP-dependent regulation of NHK proliferation that depends on phosphorylation of ERK.
Similar content being viewed by others
References
Adachi K, Halprin KM, Takeda J, Nemoto O, Aoyagi T, Iizuka H, Yoshikawa K, Levine V (1982) Epidermal surface receptors which link pharmacological mediators to adenylate cyclase system. Br J Dermatol [Suppl] 107:111–118
Stork PJS, Schmitt JM (2002) Crosstalk between cAMP and MAP kinases signaling in the regulation of cell proliferation. Trends Cell Biol 12:258–266
Fujita T, Meguro T, Fukuyama R, Nakamuta H, Koide M (2002) New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. J Biol Chem 277:22191–22200
Graves LM, Lawrence JC (1996) Insulin, growth factors, and cAMP: antagonism in the signal transduction pathway. Trends Endocrinol Metab 7:43–50
Frodrin M, Peraldi P, Van Obberghen E (1994) Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269:6207–6214
Withers DJ, Bloom SR, Rozengurt E (1995) Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J Biol Chem 270:21411–21419
Burgering BM, Pronk GJ, van Weeren PC, Chardin P, Bos JL (1993) cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12:4211–4220
Cook SJ, McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069–1072
Delescluse C, Colburn NH, Duell EA, Voorhees JJ (1974) Cyclic AMP-elevating agents inhibit proliferation of keratinizing guinea pig epidermal cells. Differentiation 2:343–350
Yamanishi K, Kishimoto S, Yasuno H (1989) Cyclic AMP as a negative regulator of DNA synthesis in FRSK cells, a fetal rat epidermal cell line. J Dermatol 16:2–6
Green H (1978) Cyclic AMP in relation to proliferation of the epidermal cells: a new view. Cell 15:801–811
Kuroki T, Ito T, Hosomi J, Munakata K, Uchida T, Nagai Y (1982) Cyclic AMP as a meiotic signal for epidermal keratinocytes, but not for dermal fibroblast. Cell Struct Funct 7:295–305
Okada N, Kitano Y, Ichihara K (1982) Effect of cholera toxin on proliferation of cultured human keratinocytes in relation to intracellular cyclic AMP levels. J Invest Dermatol 79:42–47
Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert TD, Cobb MH (1993) Regulation and properties of extracellular signal-regulated protein kinase 1 and 2 in vitro. J Biol Chem 68:5097–5106
Minden A, In A, McMahon M, Lange-Carter C, Derijard D, Davis RJ, Johnson GL, Karin M (1994) Differential activation of ERK and JNK mitogen-activated protein kinase by Raf-1 and MEKK. Science 266:1719–1723
Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ (1994) Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372:798–800
Yan M, Templeton DJ (1994) Identification of 2 serine residues of MEK-1 that are differentially phosphorylated during activation by raf and MEK kinase. J Biol Chem 269:19067–19073
Schmitt JM, Stork PJ (2000) β2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf. J Biol Chem 275:25342–25350
Namikawa K, Honma M, Abe K, Takeda M, Mansur K, Obata T, Miwa A, Okado H, Kiyama H (2000) Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 20:2875–2886
Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I (1996) Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 93:1320–1324
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199
Kanegae Y, Makimura M, Saito I (1994) A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157–166
Tsutsui M, Iizuka H, Ohkawara A, Adachi K, Kanzaki T (1987) Adenylate cyclase system of human trichilemmoma cell line. Arch Dermatol Res 279:530–535
Nakamura S, Takahashi H, Kinouchi M, Manabe A, Ishida-Yamamoto A, Hashimoto Y, Iizuka H (2001) Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes. J Dermatol Sci 25:139–149
Takahashi H, Honma M, Ishida-Yamamoto A, Namikawa K, Kiyama H, Iizuka H (2001) Human cystatin A expression of keratinocytes is positively regulated by Ras/MEKK1/MKK7/JNK signal transduction pathway and regulated by Ras/Raf-1/MEK1/ERK pathway. J Biol Chem 276:36632–36638
de Rooij J, Zwartkruis FJ, Verheijen MHG, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477
Iizuka H, Kishiyama K, Ohkawara A (1983) Regulation of beta-adrenergic adenylate cyclase responsiveness of pig skin epidermis by suboptimal concentrations of epinephrine. J Invest Dermatol 81:549–552
Iizuka H, Matsuo S, Tamura T, Ohkuma N (1988) Increased cholera toxin-, and forskolin-induced cyclic AMP accumulations in psoriatic involved versus uninvolved or normal human epidermis. J Invest Dermatol 91:154–157
Takahashi H, Tamura T, Tsutsui M, Iizuka H (1990) Adenylate cyclase system in fetal rat keratinizing epidermal cells (FRSK cells) and SV40-transformed human keratinocytes. J Dermatol 17:457–464
Bechtel PJ, Beavo JA, Krebs GC (1977) Purification and characterization of catalytic subunit of skeletal muscle adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 252:2691–2697
Byus CV, Klimpel GR, Lucas DO, Russel DH (1977) Type I and type II cyclic AMP-dependent protein kinase are opposite effectors of lymphocyte mitogenesis. Nature 268:63–64
Costa M, Gerner EW, Russel DH (1978) Cyclic AMP levels and type I and II cyclic AMP-dependent protein kinase activity in synchronized cells and in quiescent cultures stimulated to proliferation. Biochim Biophys Acta 538:1-10
Iacovelli L, Capobianco L, Salvatore L, Sallese M, D’Ancona GM, De Blasi A (2001) Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP dependent mechanism. Mol Pharmacol 60:924–933
Busca R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychene A, Ortonne JP, Ballotti R (2000) Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 19:2900–2910
Wojnowski L, Zimmer AM, Beck TW, Hahn H, Berbal R, Rapp UR, Zimmer A (1997) Endothelial apoptosis in Braf-deficient mice. Nat Genet 16:293–297
Chen T, Cho RW, Stork PJ, Weber MJ (1999) Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 59:213–218
Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275–2279
Yoshikawa K, Adachi K, Halprin KM, Levine V (1975) On the lack of response to catecholamine stimulation by the adenylate cyclase system in psoriatic lesions. Br J Dermatol 92:619–624
Iizuka H, Adachi K, Halprin KM, Levine V (1978) Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and epinephrine by the uninvolved and involved skin. J Invest Dermatol 70:250–253
Iizuka H, Hirokawa M, Ara M, Kajita S, Watanabe M, Ohkawara A (1986) Antipsoriatic and antimetabolic agents as stimulators of the beta-adrenergic adenylate cyclase response of epidermis. Clin Exp Dermatol 11:238–245
Haase I, Hobbs RM, Romero R, Broad S, Watt FM (1998) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527–536
Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hashimoto Y, Iizuka H (2002) Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci 30:94–99
Falanga V, Katz MH, Alvarez A (1991) Dibutyryl cyclic AMP by itself or in combination with growth factor can stimulate or inhibit growth of human keratinocytes and dermal fibroblasts. Wounds 3:70–78
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, H., Honma, M., Miyauchi, Y. et al. Cyclic AMP differentially regulates cell proliferation of normal human keratinocytes through ERK activation depending on the expression pattern of B-Raf. Arch Dermatol Res 296, 74–82 (2004). https://doi.org/10.1007/s00403-004-0478-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-004-0478-z